PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications.
diagnosis
prognosis
programmed cell death 1
programmed cell death ligand 1
therapy
thyroid cancer
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
20 Mar 2019
20 Mar 2019
Historique:
received:
25
02
2019
revised:
14
03
2019
accepted:
17
03
2019
entrez:
23
3
2019
pubmed:
23
3
2019
medline:
13
7
2019
Statut:
epublish
Résumé
The new immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human cancers to treat. Among these, there are the poorly differentiated and anaplastic thyroid cancers, unresponsive to all the therapies currently in use. In the present review we will summarize information regarding the expression of PD-L1 in the different thyroid cancer histotypes, its correlation with clinicopathological features, and its potential prognostic value. Then, we will evaluate the available data indicating the PD-1/PD-L1 axis as a promising target for thyroid cancer therapy.
Identifiants
pubmed: 30897754
pii: ijms20061405
doi: 10.3390/ijms20061405
pmc: PMC6471477
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Programmed Cell Death 1 Receptor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : "Sapienza" University of Rome
ID : Prot. C26A158EEK
Références
J Clin Endocrinol Metab. 2002 Sep;87(9):4391-7
pubmed: 12213904
EMBO J. 1992 Nov;11(11):3887-95
pubmed: 1396582
J Clin Endocrinol Metab. 2008 Oct;93(10):3943-9
pubmed: 18682506
J Immunol. 2009 Apr 15;182(8):4499-506
pubmed: 19342621
J Clin Endocrinol Metab. 2010 May;95(5):2325-33
pubmed: 20207826
Science. 2010 May 7;328(5979):749-52
pubmed: 20339029
Adv Cancer Res. 2010;107:57-117
pubmed: 20399961
Trends Immunol. 2010 Jun;31(6):220-7
pubmed: 20538542
Ann N Y Acad Sci. 2011 Jan;1215:79-88
pubmed: 21261644
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
Cancer Invest. 2011 May;29(4):286-92
pubmed: 21469977
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Am J Transplant. 2012 Oct;12(10):2575-87
pubmed: 22900886
Immunol Res. 2013 Mar;55(1-3):22-33
pubmed: 22941561
Ann Oncol. 2012 Oct;23 Suppl 7:vii110-9
pubmed: 22997443
Thyroid. 2012 Nov;22(11):1104-39
pubmed: 23130564
Endocr Relat Cancer. 2013 Feb 18;20(1):103-10
pubmed: 23193072
Thyroid. 2013 May;23(5):529-42
pubmed: 23317509
Int J Cancer. 2014 Jan 15;134(2):319-31
pubmed: 23818246
Endocr Relat Cancer. 2014 Apr 28;21(3):R85-R103
pubmed: 24302667
Folia Histochem Cytobiol. 2014;52(1):18-28
pubmed: 24802957
Thyroid. 2014 Sep;24(9):1385-93
pubmed: 24955518
Int J Endocrinol. 2014;2014:816430
pubmed: 25097550
Expert Opin Ther Targets. 2014 Dec;18(12):1407-20
pubmed: 25331677
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Nature. 2014 Nov 27;515(7528):558-62
pubmed: 25428503
Nature. 2014 Nov 27;515(7528):563-7
pubmed: 25428504
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Pathol Oncol Res. 2015 Jul;21(3):695-701
pubmed: 25588542
Mol Cancer Ther. 2015 Apr;14(4):847-56
pubmed: 25695955
Cancer Immunol Res. 2015 Jun;3(6):620-30
pubmed: 25701326
N Engl J Med. 2015 May 21;372(21):2018-28
pubmed: 25891174
J Immunother Cancer. 2015 Apr 21;3:15
pubmed: 25901287
Pharmacotherapy. 2015 Oct;35(10):963-76
pubmed: 26497482
Eur J Endocrinol. 2016 Apr;174(4):R117-26
pubmed: 26510840
Front Endocrinol (Lausanne). 2015 Nov 20;6:176
pubmed: 26635725
Head Neck. 2016 Apr;38 Suppl 1:E1122-9
pubmed: 26879282
Oncotarget. 2016 Mar 29;7(13):17194-211
pubmed: 26943572
J Clin Endocrinol Metab. 2016 Jul;101(7):2863-73
pubmed: 27045886
JAMA Oncol. 2016 Aug 1;2(8):1023-9
pubmed: 27078145
Hum Pathol. 2016 Aug;54:134-42
pubmed: 27085556
Oncotarget. 2016 May 31;7(22):32318-28
pubmed: 27086918
Steroids. 2016 Oct;114:59-67
pubmed: 27221508
Endocr Pathol. 2016 Sep;27(3):205-12
pubmed: 27372303
Cell Immunol. 2016 Dec;310:27-41
pubmed: 27660198
Cancer Cytopathol. 2016 Oct;124(10):699-710
pubmed: 27717284
Cancer. 2017 Feb 1;123(3):372-381
pubmed: 27741354
Thyroid. 2017 Apr;27(4):537-545
pubmed: 27825291
Front Immunol. 2016 Dec 12;7:550
pubmed: 28018338
Mol Cell Endocrinol. 2017 Mar 5;443:121-127
pubmed: 28089820
Endocr Relat Cancer. 2017 Feb;24(2):97-106
pubmed: 28093480
Thyroid. 2017 Apr;27(4):481-483
pubmed: 28114862
Ann Oncol. 2017 Apr 1;28(4):874-881
pubmed: 28168303
J Clin Endocrinol Metab. 2017 Jun 1;102(6):1943-1950
pubmed: 28324060
Int J Endocrinol. 2017;2017:9692304
pubmed: 28348589
Int J Oncol. 2017 Mar 08;:null
pubmed: 28350047
EBioMedicine. 2017 Apr;18:11-12
pubmed: 28363611
EBioMedicine. 2017 Apr;18:50-55
pubmed: 28363612
Histopathology. 2017 Sep;71(3):357-365
pubmed: 28383817
Endocr Pract. 2017 Aug;23(8):979-988
pubmed: 28534687
Nat Rev Endocrinol. 2017 Nov;13(11):644-660
pubmed: 28707679
Oncologist. 2017 Oct;22(10):1149-1151
pubmed: 28778959
Int J Mol Sci. 2017 Aug 11;18(8):null
pubmed: 28800068
Diagn Pathol. 2017 Oct 3;12(1):72
pubmed: 28974264
Surgery. 2018 Jan;163(1):130-136
pubmed: 29128181
Expert Rev Anticancer Ther. 2018 Feb;18(2):149-159
pubmed: 29241377
Endocr Pathol. 2018 Mar;29(1):59-67
pubmed: 29372535
Thyroid. 2018 Mar;28(3):349-361
pubmed: 29455638
Mol Cancer. 2018 Feb 19;17(1):51
pubmed: 29455653
Endocr Relat Cancer. 2018 May;25(5):523-531
pubmed: 29507047
Oncol Rep. 2018 May;39(5):2225-2234
pubmed: 29517103
Endocr Relat Cancer. 2018 May;25(5):533-545
pubmed: 29555649
Clin Cancer Res. 2018 Jul 1;24(13):3059-3068
pubmed: 29615459
Virchows Arch. 2018 May;472(5):779-787
pubmed: 29651624
Oncotarget. 2018 Apr 13;9(28):19767-19782
pubmed: 29731981
J Immunother Cancer. 2018 Jul 11;6(1):68
pubmed: 29996921
Expert Rev Endocrinol Metab. 2017 Jul;12(4):279-288
pubmed: 30058884
Int J Endocrinol. 2018 Jul 5;2018:1742951
pubmed: 30123257
Int Immunopharmacol. 2018 Nov;64:333-339
pubmed: 30243069
Pharmacol Ther. 2019 Feb;194:84-106
pubmed: 30268773
Int J Cancer. 2019 May 1;144(9):2266-2278
pubmed: 30515783
Cancers (Basel). 2018 Dec 05;10(12):null
pubmed: 30563160
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Endocrine. 2019 Apr;64(1):122-129
pubmed: 30762153
BMC Cancer. 2019 Mar 4;19(1):196
pubmed: 30832606
F1000Res. 2019 Feb 28;8:null
pubmed: 30854191
Genomics. 1994 Oct;23(3):704-6
pubmed: 7851902
Thyroid. 1998 May;8(5):361-9
pubmed: 9623725
J Clin Endocrinol Metab. 1998 Nov;83(11):4130-9
pubmed: 9814503